It's no laughing matter. Hyperadrenergic POTS attacks can send patients rushing to the emergency room. First Geoff tells his hyperPOTS story, then we dig deep into what it is, the new diagnostic criteria, a drug that can help, and a new form of that was recently discovered.
Only 10 major long COVID clinical trials have been published thus far but that's enough to come away with some interesting takeaways. They include treatments that prevent long COVID don't necessarily treat it, broader based treatments are probably best, manipulating the gut can help with fatigue (but only so much), and an as yet unassessed class of drugs may be helpful.
Check out the The free RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide and why we may FDA approved drugs for long COVID quicker than you might think.
Geoff’s Narration The GIST “These substances represent a potentially revolutionary approach to pharmacological pain management,” Crozpek et. Al. 2025 History has shown that our notions of what treatments can do are quite limited. Numerous...
The big IMPACC long COVID study findings suggest that inflammation and reduced male sex hormone levels may be playing havoc with the small blood vessels in long COVID -= and ME/CFS
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.